Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Other Short-Term Financial Investments
QFRD210385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
25,548.00
Year-over-Year Change
-7.63%
Date Range
10/1/2000 - 4/1/2025
Summary
This trend tracks quarterly short-term financial investments by U.S. pharmaceutical and medicine corporations. It provides critical insights into corporate financial strategies and liquidity management within a key healthcare sector.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The data represents financial allocation decisions made by pharmaceutical companies regarding their liquid assets and investment portfolios. Economists analyze these investments as indicators of sector confidence, cash flow management, and potential strategic positioning.
Methodology
Data is collected through comprehensive quarterly financial reporting by corporations in the pharmaceuticals and medicines industry, compiled and standardized by federal economic research agencies.
Historical Context
This trend is used by financial analysts, policymakers, and investors to assess corporate financial health, investment trends, and potential economic indicators in the healthcare sector.
Key Facts
- Represents quarterly financial investment data for U.S. pharmaceutical corporations
- Provides insights into corporate financial strategy and liquidity management
- Tracked and reported by federal economic research institutions
FAQs
Q: What does this economic trend measure?
A: It measures short-term financial investments made by U.S. pharmaceutical and medicine corporations on a quarterly basis.
Q: Why are these investments important?
A: These investments indicate corporate financial health, strategic planning, and potential economic trends in the healthcare sector.
Q: How frequently is this data updated?
A: The data is typically updated quarterly, providing a current snapshot of corporate financial strategies.
Q: Who uses this economic trend?
A: Financial analysts, investors, policymakers, and researchers use this trend to understand corporate financial dynamics.
Q: What are the limitations of this data?
A: The data represents a specific sector and may not fully capture the entire economic landscape or individual corporate variations.
Related News
Gen Z In the U.S. Shifts From Spending To Saving Habits
How Gen Z's Shift from Spending to Saving is Impacting the US Economy Recent trends indicate a significant shift in the spending habits of Gen Z, w...
U.S. Treasury Yields Decline After Inflation Data Meet Expectations
US Treasury Yields Drop as Inflation Data Meets Expectations US Treasury yields have seen a noticeable decline recently, as the latest inflation da...
S&P 500 Rises With Optimistic U.S. Inflation Report
S&P 500 Soars: Positive U.S. Inflation Developments The S&P 500, a primary stock index that tracks the performance of 500 major U.S. companies, has...
U.S. Stock Market Rises Amid PCE Inflation Report Analysis
U.S. Stock Market Climbs Amidst Insights from PCE Inflation Report Investors in the U.S. stock market are focusing on the most recent PCE Inflation...
U.S. GDP Growth to Slow Due to Tariffs and Immigration Policies
How Tariffs and Immigration Policies Influence U.S. GDP Growth in 2025 The U.S. GDP is a fundamental gauge of the country's economic health. Recent...
U.S. Stock Market Futures Rise On Inflation and Tariff News
US Stock Market Futures Rise Amid Inflation Data and Tariff News US stock market futures are on the rise, driven by significant updates in inflatio...
Related Trends
Quarterly Financial Report: U.S. Corporations: All Nondurable Manufacturing: Income (Loss) After Income Taxes
QFR115NDUUSNO
Quarterly Financial Report: U.S. Corporations: All Retail Trade: Income (Loss) Before Income Taxes
QFR111RETUSNO
Quarterly Financial Report: U.S. Corporations: Chemicals: Net Property, Plant, and Equipment
QFR219CHEUSNO
Quarterly Financial Report: U.S. Corporations: Chemicals: Total Liabilities
QFRTLCHEUSNO
Quarterly Financial Report: U.S. Corporations: Food and Beverage Stores: Total Liabilities and Stockholders' Equity
QFR328445USNO
Quarterly Financial Report: U.S. Corporations: Machinery: Total Cash on Hand and in U.S. Banks
QFRTCASH333USNO
Citation
U.S. Federal Reserve, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Other Short-Term Financial Investments [QFRD210385USNO], retrieved from FRED.
Last Checked: 8/1/2025